Stocks · Health care · Pharmaceutical Preparations

ABEONA THERAPEUTICS INC.

ABEO Clue Score64
United States Fiscal year ends December CIK 0000318306 Results filed 13 Aug 2026

What the insiders did No buying or selling

By person

13 insiders · 0 transactions
10.0×

Vishwas Seshadri holds 10.0 times base salary in stock. $6.63M of shares against $662.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Vishwas Seshadri last reported holding, valued at $5.16, the price Common Stock was last bought or sold at on the open market here, on 29 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Vishwas Seshadri
Chief Executive Officer
—
—
—
1,286,500
$6.63M
+42.3%
Joseph Walter Vazzano
Chief Financial Officer
—
—
—
482,888
$2.49M
+32.2%
Brendan M. O'Malley
SVP, Chief Legal Officer
—
—
—
421,226
$2.17M
+54.1%
Madhav Vasanthavada
Chief Commercial Officer
—
—
—
285,721
$1.47M
+12.2%
Michael Amoroso
Director
—
—
—
217,779
$1.12M
+50.9%
Faith L. Charles
Director
—
—
—
176,407
$909.48K
+55.1%
Donald A. Wuchterl
Director
—
—
—
167,935
$865.81K
+46.7%
Leila Alland
Director
—
—
—
162,614
$838.37K
+37.5%
Christine Berni Silverstein
Director
—
—
—
119,562
$616.41K
+22.7%
Bernhardt G Zeiher
Director
—
—
—
84,458
$435.43K
+664.7%
Mark Alvino
Director
—
—
—
62,065
$319.98K
−14.1%
Eric Crombez
Director
—
—
—
37,313
$192.37K
+237.9%
Keith A. Goldan
Director
—
—
—
32,751
$168.85K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.